India's primary market is running hot — September alone saw more than 34 companies collectively raise ₹39,380 crore, about 42% of all funds mobilised so far in FY2026-27, per IANS reporting on October 13. Into this packed IPO calendar, SEBI has given issuers a bigger cushion: the regulator has extended a temporary relaxation letting IPO-bound companies revise the size of their fresh issue by up to 50% — up or down — without filing a fresh Draft Red Herring Prospectus. The extension was communicated to the Association of Investment Bankers of India (AIBI) in an email dated October 12, and reported on October 13 (Reuters; Financial Express). This is not minor procedure: it changes what can move between SEBI's approval and the IPO opening — which changes how you read IPO documents as a retail investor. **Quick Answer:** What did SEBI change for investors? Until March 31, 2027, IPO-bound companies can revise their fresh-issue size by up to 50% without filing a fresh DRHP — under normal rules, anything beyond 20% forces a refile that delays the IPO by 30–75 days. Because issue sizes can shift after approval, read the DRHP addendum, not just the original prospectus.

What SEBI actually changed

Three things, all reported on October 13 across Reuters, Financial Express, Fortune India, and IANS: **1. The deadline moved.** Introduced in April 2026 and due to expire on September 30, 2026, the relaxation now covers IPOs opening **on or before March 31, 2027** — effectively through the rest of FY2026-27. **2. The permitted revision stays at 50%.** A company that has filed its draft documents can increase or decrease the **fresh issue component** — new shares issued, with the money going to the company — by up to 50%, without new draft offer documents. The book-running lead managers (BRLMs) file updated offer documents instead. **3. It followed industry representations.** The decision followed AIBI representations about the challenges of revising fresh-issue sizes mid-process (Reuters), and applies to all IPOs opening on or before March 31, 2027. One precision point: this covers only the fresh issue portion — not the offer-for-sale (OFS) component, where existing shareholders sell their own shares. **The backstory.** The measure dates to early April 2026, when West Asia tensions were unsettling markets — SEBI wanted issuers to be able to recalibrate fundraising without the 30–75 day refile penalty. It was meant to last six months, but stakeholders told SEBI the conditions hadn't gone away (IANS), and the October 13 extension keeps the flexibility for another six months.

Why it matters: the normal rule and the 30–75 day delay

To see why bankers asked for this, compare with SEBI's normal ICDR (Issue of Capital and Disclosure Requirements) Regulations, 2018 position: Under the normal rule: - Once a DRHP is filed, any deviation **exceeding 20%** in the estimated fresh issue size forces the company to withdraw and file a fresh DRHP. - A fresh filing resets the regulatory clock — updated disclosures, re-examination by SEBI — typically delaying the IPO by **30 to 75 days** (Flash Finance). For a company already holding SEBI's observation letter, a market correction could mean letting the approval lapse or proceeding with an ill-fitting issue size. Under the relaxed rule (now valid till March 31, 2027): - The fresh issue component can move **up to 50% in either direction** without a fresh DRHP, on a case-by-case basis — so the IPO stays on schedule while the fundraising amount is recalibrated to market conditions.

The safeguards: freedom with guardrails

SEBI did not hand issuers a blank cheque. The conditions (Financial Express, IANS, Fortune India): 1. **The primary objective of the issue must not change.** The stated purpose of the money — debt repayment, capex, general corporate purposes — stays fixed; BRLMs may only file updated documents if it is unchanged. 2. **The revision must be justified.** Merchant bankers must provide a proper justification for the change — not vague language. 3. **Lead managers certify compliance.** BRLMs must conduct adequate due diligence and certify that the revision complies with all relevant regulations. 4. **Public disclosure via an addendum.** Every revision must be disclosed through a **public addendum** to the DRHP — the document retail investors must now watch. 5. **Full regulatory compliance continues.** The relaxation waives only the refile — not disclosure, due diligence, or any other investor-protection requirement.

What it means for you as a retail IPO investor

Before this relaxation, the issue size in a DRHP was relatively stable — anything beyond a 20% move forced a refile, so the draft prospectus was close to the final deal. For any IPO opening on or before March 31, 2027, that size can now legitimately move by **up to 50%** between approval and launch. **The DRHP addendum is now as important as the DRHP.** An addendum publicly updates the original draft prospectus. If you read a company's DRHP when it was filed months ago and never checked back, you could walk into the subscription window with stale numbers — a different issue size and different dilution arithmetic. **Subscription-day valuation and dilution math can shift.** A simple hypothetical example (not any real company): suppose a DRHP showed a fresh issue of ₹4,000 crore at ₹200 per share — 20 crore new shares — against 100 crore existing shares. A 50% upward revision to ₹6,000 crore means 30 crore new shares: existing shareholders' dilution rises from roughly 16.7% to roughly 23% of post-issue capital, and the implied post-money valuation shifts materially. A downward revision flips the arithmetic the other way: less dilution, but less money raised for the stated objectives. The discipline is straightforward: treat the original DRHP's issue size as a starting point, and verify the final figures in the addendum and the Red Herring Prospectus (RHP) filed closer to the offer. Valuation multiples computed from the DRHP need recomputing once the addendum lands.

What to watch this IPO season

The extension lands in the busiest primary-market season in recent memory, with a heavy pipeline through March 2027. Three things to watch: **1. How often companies use it.** Each revision is disclosed in a public addendum — watch for them in the offer documents of IPOs you're interested in. **2. Whether objectives truly stay put.** The primary objective cannot change. If an addendum ever appears to shift the *purpose* of the money alongside the size, that is what the safeguard is meant to prevent. **3. The direction of revisions.** Upsizes and downsizes both reflect market conditions — but treat either as one data point, not a verdict on company quality. Your core IPO homework (business model, financials, risks, valuation versus peers) remains what matters. **Your 5-point IPO addendum checklist:** 1. Read the latest addendum before you apply — never rely on a saved or printed DRHP from months ago; the fresh-issue size may have moved by up to 50%. 2. Re-check three numbers in the addendum: the revised fresh-issue size, the price band, and the post-issue share capital/dilution figures. 3. Confirm the primary objective of the issue is unchanged — use-of-proceeds should match the original DRHP. 4. Read the banker's stated justification for the revision; it should connect to market conditions or business requirements. 5. Keep your usual IPO discipline: business quality, risk factors, valuation versus listed peers, and your own pre-decided allocation limit for any single IPO.

Frequently Asked Questions

**1. What exactly did SEBI extend on October 13, 2026?**
**2. What is a DRHP addendum, and where do I find it?**
**3. Does the 50% relaxation apply to the offer-for-sale portion too?**
**4. Why did SEBI introduce this in the first place?**
**5. What if a company wants to change the issue size by more than 50%?**
**6. Should I be worried if an IPO I like revises its issue size under this rule?**

**Your next step:**

(1) Before your next IPO application, pull up the latest DRHP addendum — not the original DRHP — and note any change in fresh-issue size. (2) Recompute valuation and dilution numbers with the revised figures; old screenshots go stale under this rule. (3) Write down your single-IPO allocation limit before any subscription window opens, so market noise never makes the decision for you.

Learn More
**Sources:** Reuters — "India's SEBI extends easier IPO rules till March 2027, bankers lobby says" (Oct 13, 2026); Financial Express — "SEBI extends IPO fresh issue size revision relaxation up to 50% till March 31, 2027" (Oct 13, 2026); Fortune India — "SEBI Extends IPO Size Revision Flexibility to March 2027; AIBI Applauds Decision" (Oct 13, 2026); IANS via Lokmat Times and Orissa Post — "SEBI extends IPO issue-size flexibility till March 2027" (Oct 13, 2026); Flash Finance — "SEBI Extends IPO Issue Size Revision Relaxation by Up to 50%" (Oct 13, 2026), for the standard 20% ICDR threshold and the 30–75 day refile delay; IANS via Lokmat Times/Orissa Post (Oct 13, 2026), for September's 34+ IPOs raising ₹39,380 crore (~42% of FY2026-27 funds mobilised so far). The dilution example is a hypothetical worked example, not data from any real company.
DISCLAIMER: This article is for educational purposes only and is not financial advice. Please consult a SEBI-registered investment adviser for personalized guidance. Investments are subject to market risk.